Background: non-adherence is a common cause of treatment failure. The causes and context of non-adherence may differ amongst older people and reviews of interventions to improve adherence have tended to focus on the younger adult population. Objective: to conduct a systematic review of interventions to aid adherence to medication for older people over the age of 65. These were then hand-searched. The papers that Wtted our inclusion criteria were selected. Two independent reviewers using an established tool assessed the studies for methodological quality. A non-statistical narrative approach was then taken to analyse the studies due to the heterogeneity of the outcome measures. Results: 7 studies were identiWed. They used a variety of approaches involving external cognitive supports and/or educational interventions. Most studies were of poor methodological quality. Statistically signiWcant effects, where present, tended to have small effects clinically. Conclusions: currently there is no strong evidence to support the use of any one intervention type. Future research should use combinations of approaches, as there is some evidence that these are more likely to be successful.
Introduction
Non-adherence or 'non-compliance' with medication is common. Around 40-60% of patients do not take medication as prescribed [1] and this can lead to treatment failure, further physical or mental health problems, service costs and carer burden [2] . As the over-65 population is the fastest growing cohort and the most likely population to be prescribed tablets, problems associated with non-adherence in this age group are likely to increase [3] . Effective adherence interventions to address this issue would therefore be valuable.
Adherence behaviour is a complex area with biomedical, psychological and anthropological explanations competing for attention. In general terms, patient attitudes, social circumstances, medication side effects and the nature of the patient-doctor relationship have been postulated as important inXuences [4] .
Taking an overview of progress in this area is problematic. Non-adherence as a phenomenon spans medical disciplines but research by its nature tends to be discipline speciWc in outlook, often limited to a speciWc diagnosis or medication; it can therefore be difWcult to bring papers meaningfully together for meta-analysis [5] . A systematic review of adherence interventions looking at unconfounded randomised trials amongst the younger adult population found only 15 studies; seven demonstrated improved adherence, six of which led to improvements in treatment outcomes [2] . This review concluded that effective interventions were complex, combining approaches such as counselling, information, reminders and family therapy; statistically signiWcant positive Wndings did not however lead to worthwhile improvements in clinical outcome. Most meta-analyses include only papers that are methodologically robust; however, as most research in this area is small scale, adherence is often a secondary outcome measure nested within a larger study, and the quality of papers tends to be poor [1] . As a consequence most relevant papers are excluded and therefore not disseminated in the literature beyond the conWnes of the medical discipline from Interventions to help older people adhere to medication which they originated. A recent meta-analysis that did include less statistically robust papers amongst the younger adult population broadly agreed in its Wndings with the review described above, and concluded there was no clear advantage to any one strategy over another [5] .
Extrapolating research Wndings from younger adults to older people is problematic. Older people may differ in their experience of illness and medication and, in addition, may share different tendencies in their attitudes towards adherence. Published research often excludes the older population, usually without justiWcation [6] . Amongst the over-65 population, chronic illness, subtle or frank cognitive deWcits, co-morbidity and associated complicated treatment regimes may all further complicate the picture [7] . This systematic review therefore speciWcally focuses on how to improve medication adherence amongst older people over the age of 65. We expected that effective adherence interventions would be complex, in keeping with Wndings amongst younger adults as described above. As the literature in this area is sparse this review is broad in scope, including all trials of adherence interventions for older people regardless of illness, treatment setting or intervention type used.
Method Inclusion criteria
The inclusion criteria were as follows: Wrstly a focus on the 65 and over age group, secondly demonstration of an intervention to improve medication adherence, thirdly the inclusion of a control group and fourthly publication in an English language journal between 1966 and 2002. Studies addressing adherence to interventions other than medication were excluded.
Search strategy
The following databases were searched using the terms 
Data extraction and analysis
A data extraction form was developed to judge the methodological quality of the papers to allow the assessment of the studies to be reproducible. The methodological quality was judged on the basis of a tool developed by Nichol et al. 1999 [1] speciWcally for the evaluation of medication adherence interventions. The criteria used were as follows: use of randomisation, description of randomisation procedure, blinding, power analysis, speciWcation of patient sample, speciWcation of illness, speciWcation of therapeutic regime, duration of follow-up, clear deWnitions of adherence/ adherence measurement and an account of all patients at the end of the study. Although this tool was originally used to calculate a composite score for methodological quality, this approach has not been used here: composite scores are often neither valid nor reliable in practice. There is also no gold standard for trial methodological quality as such [8] . The two authors of this study (N.H. and C.R.) assessed the studies' methodological quality independently using this tool. Discrepancies were subsequently resolved by referring to the original studies. A non-statistical narrative approach was used to analyse the data: given the heterogeneity of the outcome measures, the few papers involved and the overall poor statistical quality, a statistical meta-analysis was not appropriate.
Results
From the search, 1,925 study titles were identiWed using the above criteria. After screening these titles and reading all potentially relevant abstracts, 43 studies were judged potentially relevant. These were traced and read in full, leaving seven studies remaining that satisWed our inclusion and exclusion criteria.
The interventions fell broadly within two categories: external cognitive supports involving the mechanics of medication delivery and education strategies, though several interventions combined elements of both. Individual study characteristics are shown in Table 1 and their outcomes in Table 2 . One study used physical aids to help organise and remind people about time and dose of medication: Ware et al. (1991) used calendar blister packs. Improvement in adherence occurred when the blister pack was combined with cognitive support. Education strategies varied considerably in nature and had mixed success. Information was provided in a variety of formats, including face-to-face instruction, telephone consultations and written information. In some instances education was provided as part of a package including self-medication programmes and pharmacist medication review.
The quality of the studies varied considerably, as shown in Table 3 . All but one used randomisation, but the procedure used was described in only four (Lourens and Woodward, 1993 ; Levens-Lipton and Bird, 1994; Esposito, 1995; Nazareth et al., 2001) . Notably these were the only ones, apart from Esposito (1995) , to use a power calculation for their sample sizes. Potential investigator bias was poorly addressed; only two studies (Levens-Lipton and Bird, 1994; Nazareth et al., 2001) used a blind rater to assess outcome. Two of the studies assessed adherence based on tablet counts alone, three used patient interview alone and two combined both of these methods. Six of the studies calculated an adherence score using these measures but these varied in nature, as discussed below. One of the studies simply generated dichotomous categories of 'compliant' and 'non-compliant' patients. Two of the seven had short follow-up periods of a month or less, one study had a follow-up period of between 3 and 6 weeks. None of the studies used an intention to treat analysis, whereby patients who withdraw are analysed in the group to which they were originally allocated.
It is of note that during our search we identiWed several studies that were focused on older adults but had younger age criteria (e.g. 55 years and over) than studied here (65 years and over). These studies appeared to be similar in the type of approaches used and their methodological difWculties as those described above.
Discussion
Overall the Wndings of this review echo the meta-analyses of adherence interventions in younger adults outlined above. Firstly our initial belief was upheld, i.e. effective interventions were complex. Single discrete interventions were disappointing and positive effects were only found with combinations of approaches. Secondly, results were mixed and statistically signiWcant positive effects tended, clinically, to be small. Thirdly, a consistent Wnding was that generally studies were not of a high standard methodologically (with randomisation, blind raters, power analyses, speciWed patient samples, all patients being accounted for, intention to treat analyses, recognised outcome measurements and clearly deWned objectives), with the notable exception of Nazareth et al. (2001) , which found no signiWcant effect for their intervention. Interestingly, this paper is the most recent to be published.
The applicability of controlled trials to investigate complex interventions in psychiatry has been called into question [9] . Firstly, it is notoriously difWcult to standardise interactions with patients. The studies employing some form of education were not clear as to how this was provided, e.g. the degree to which sessions were didactic in nature. It is of note that all the educational interventions bar two (Esposito, 1995; Wolfe and Schirm, 1992) were provided by pharmacists who may not have clinical experience. Thus it is difWcult to bring these studies together as evidence for the utility (or otherwise) of educational approaches. In addition the reproducibility of the interventions in one's own clinical practice is difWcult to gauge. A second problem with complex interventions is that they contain multiple elements, such as oral instruction and medication reviews; it is therefore difWcult to conclude what aspects are effective or otherwise. Many of these studies blended elements that individually might appear to be common sense, for instance the conversion of complex regimes to twice daily dosing. This is an intuitively appealing idea, argued by some to be the single most important approach to improving adherence [10] .
There was an implicit aetiological assumption underpinning all the interventions, mainly that non-adherence stems from a lack on the patient's behalf-either of knowledge or cognitive organisation-to be remedied by appropriate supplementation. This approach originates from within the classical biomedical paradigm. In the studies under consideration here, information appears to have been administered as if analogous to a discrete pharmaceutical intervention. That is to say the patient has been understood to be a passive recipient, with the context for this process as irrelevant 'noise' in the study design to be adjusted for in the analysis. None of the interventions directly tackled the issue Interventions to help older people adhere to medication that a patient might actively choose not to take medication and none sought to elicit patients' attitudes to medication as a potential mediator of adherence.
There was a lack of consensus as to how adherence should be calculated. The gold standard has been argued to be serum or urine analysis, but this is invasive and complicated by individual differences in drug metabolism [11] . Such techniques also implicitly reject patient self-report, taking a stance that now seems paternalistic and outdated-no study here employed such methods. Each study devised their own idiosyncratic scoring system, ranging from dichotomous 'adherent' or 'non-adherent' outcomes to complex calculations, used in conjunction with pharmacist tablet count or patient self-report. This variation makes comparison between study adherence outcomes difWcult and whilst dichotomous measures may over-simplify, complex calculations made analysis unwieldy and, at points, confusing.
The control groups were all markedly adherent, in keeping with younger adult study populations. This may in part be due to the Hawthorne effect, i.e. the effect of being observed in a study. Those agreeing to take part may also represent the more engaged and adherent end of the patient spectrum. Only two studies (Esposito, 1995; Nazareth et al., 2001) actually assessed patients' cognitive function as a potential confounder, despite the methodology of several of the studies implying that lack of cognitive organisation was aetiologically important in this group (reXecting perhaps a stereotype of older people as cognitively impaired).
One might assume that a strategy leading to improved adherence would ultimately lead to health care savings but only the Levens-Lipton and Bird (1994) study performed a thorough cost-analysis to test this. They found that although adherence improved with their intervention this did not translate into fewer hospital admissions or subsequent lower costs. The difference between a statistically signiWcant and economically signiWcant result is pertinent here.
The results of this review do not lend support for the common assumption that adherence will follow knowledge or justify improving knowledge for its own sake. This is perhaps not surprising when one considers that knowledge is of little use to a patient if they do not believe it pertains to them. Testing knowledge may, theoretically at least, be stressful for a patient and therefore raises ethical issues. It is interesting to note a Cochrane review's ethical guidelines on adherence intervention trials develop this argument further by stipulating that adherence by itself is not a justiWable end-point but should be measured in combination with meaningful clinical outcomes [2] . Only one study here took such a broader perspective; Levens-Lipton and Bird (1994) analysed hospital service use alongside adherence and medication knowledge.
Limitations of this review
The main limitation of this overview was that the search was limited to English language publications. In addition the review focused on interventions to improve medication adherence; any potentially relevant interventions to improve adherence with other health care interventions, such as diet or exercise, were therefore not included.
Conclusion
There is not yet any strong evidence to support the use of any one type of intervention to help improve adherence amongst older people. Most research thus far has not been of a high standard methodologically and is difWcult to bring together due to the heterogeneity of the studies involved. This said, the Wndings of this review do suggest that there may well be a role for cognitive supports and educational interventions. It would therefore be worth investigating these approaches further in future with well-designed studies that address possible confounding factors (e.g. cognition) and employ valid outcome measures. Most importantly for future research it is likely that successful interventions will be those employing sophisticated combinations of approaches tailored to a patient's individual needs.
Key points
• There are few published controlled trials of adherence interventions for people over the age of 65.
• Studies thus far have tended to be of poor methodological quality and their results difWcult to interpret clinically.
• There is no robust evidence supporting any one type of approach.
• Successful interventions are likely to be combinations of educational interventions and cognitive supports.
